Clinical Trials in Tennessee

Showing 16861-16880 of 20,239 trials

A Phase III Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Investigational Product MP-101 in Subjects With Short Bowel Syndrome Who Have Had an Inadequate Response to Anti-Diarrheals

NCT02242656

MP-101 will be evaluated in this study to see if it is safe, tolerable, and can help people with Short Bowel Syndrome. This study will also find out if taking MP-101 can improve the symptoms of Short Bowel Syndrome and reduce the number of times subjects experience bowel movements.

Short Bowel SyndromeShort Gut SyndromeSBS+2 more

Marathon Pharmaceuticals, LLCStarted Dec 2014

Chicago, Illinois, United States • Indianapolis, Indiana, United States • Cleveland, Ohio, United States +2 more locations

WITHDRAWNPhase 329 miles

A Open Label Extension Study for Subjects That Complete Study MP-101-CL-001

NCT02246816

MP-101 will be evaluated in this study to see if it is safe and tolerable.

Short Bowel SyndromeShort Gut SyndromeSBS+1 more

Marathon Pharmaceuticals, LLCStarted Feb 2015

Chicago, Illinois, United States • Indianapolis, Indiana, United States • Cleveland, Ohio, United States +2 more locations

A Phase III Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Investigational Product MP-101 in Subjects With Short Bowel Syndrome Who Have Had an Inadequate Response to Anti-Diarrheals

A Open Label Extension Study for Subjects That Complete Study MP-101-CL-001

Find Trials by Condition in Tennessee

Peds Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels

A Study of NK012 in Patients With Advanced, Metastatic Triple Negative Breast Cancer

hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma

Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies

Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes Mellitus

Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia

Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza

Randomized Controlled Trial of Long-term Treatment Effectiveness for Meibomian Gland Dysfunction (MGD) and Dry Eye

A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies

Study of Physiological and High Dose Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast Cancer

Atazanavir/Ritonavir, Once Daily + Raltegravir, Twice Daily, Switch Study in HIV-1-Infected Patients

Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age

Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY

Study to Evaluate Apo805K1 in Subjects With Moderate to Severe Chronic Plaque Psoriasis

A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer

Safety Extension Study to Evaluate the Biodegradation of the Brimonidine Tartrate Posterior Segment Drug Delivery System